IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GRISANTI, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.214
EU - Europa 2.462
AS - Asia 1.821
AF - Africa 23
SA - Sud America 19
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.547
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.178
SG - Singapore 581
CN - Cina 549
IT - Italia 469
UA - Ucraina 417
HK - Hong Kong 388
PL - Polonia 368
DE - Germania 311
FI - Finlandia 217
RU - Federazione Russa 201
TR - Turchia 133
IE - Irlanda 131
GB - Regno Unito 90
FR - Francia 73
CZ - Repubblica Ceca 52
ID - Indonesia 49
SE - Svezia 37
IN - India 34
VN - Vietnam 32
CA - Canada 28
BE - Belgio 26
NL - Olanda 17
JP - Giappone 16
AT - Austria 10
CH - Svizzera 9
GR - Grecia 8
AZ - Azerbaigian 7
PT - Portogallo 7
AR - Argentina 5
IR - Iran 5
LY - Libia 5
PE - Perù 5
AU - Australia 4
BR - Brasile 4
MA - Marocco 4
MU - Mauritius 4
TW - Taiwan 4
ZA - Sudafrica 4
AL - Albania 3
EG - Egitto 3
EU - Europa 3
KR - Corea 3
PA - Panama 3
CL - Cile 2
CR - Costa Rica 2
EE - Estonia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LT - Lituania 2
LV - Lettonia 2
MX - Messico 2
NO - Norvegia 2
PH - Filippine 2
RO - Romania 2
TH - Thailandia 2
UZ - Uzbekistan 2
ZW - Zimbabwe 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
CM - Camerun 1
CO - Colombia 1
CY - Cipro 1
ES - Italia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 9.547
Salva come PNG Salva come JPEG
Città #
Fairfield 746
Woodbridge 532
Singapore 496
Ashburn 441
Hong Kong 384
Houston 384
Warsaw 366
Jacksonville 308
Cambridge 305
Seattle 304
Chandler 301
Wilmington 246
Princeton 178
Helsinki 173
Ann Arbor 166
New York 154
Istanbul 130
Dublin 99
Beijing 90
Moscow 86
Nanjing 86
Brescia 76
Boardman 70
Shanghai 61
Dearborn 50
Jakarta 48
Los Angeles 48
Munich 43
Brno 42
Milan 39
San Diego 35
Des Moines 34
Nanchang 34
Dong Ket 32
Changsha 29
Dalmine 29
Romola 29
Washington 27
Brussels 26
West Jordan 26
Shenyang 25
Menlo Park 22
Lancaster 21
Jinan 19
Tianjin 17
Hebei 16
London 16
Naples 16
Toronto 16
San Francisco 13
Hangzhou 12
Vignate 12
Nuremberg 11
Guangzhou 10
Jiaxing 10
Kunming 10
Pune 10
Turin 10
Verona 10
Zhengzhou 10
Gumyojicho 9
Haikou 9
Ningbo 9
Olomouc 9
Taizhou 9
Chicago 8
Athens 7
Falls Church 7
Lanzhou 7
Lappeenranta 7
Redwood City 7
Rome 7
Santa Clara 7
Cazzago San Martino 6
Falkenstein 6
Fukuoka 6
Leawood 6
Livorno 6
Baku 5
Buenos Aires 5
Ottawa 5
Perugia 5
Vienna 5
Brusaporto 4
Calcinate 4
Espoo 4
Frankfurt am Main 4
Gunzenhausen 4
Lima 4
Lisbon 4
New Bedfont 4
North York 4
Norwalk 4
Phoenix 4
San Mateo 4
Ventimiglia 4
Zurich 4
Ardabil 3
Augusta 3
Benghazi 3
Totale 7.261
Salva come PNG Salva come JPEG
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 195
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy 180
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 178
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 171
Immunotherapy failure in adrenocortical cancer: where next? 167
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 159
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 155
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 155
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 150
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 149
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 149
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 149
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 147
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 145
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 136
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 134
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 126
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 125
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 120
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 120
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 119
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 118
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 118
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 116
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 115
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 114
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 114
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 113
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 112
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 112
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 111
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 111
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 110
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 109
Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial Update 106
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 104
Idiopathic intracranial hypertension: A possible complication in the natural history of advanced prostate cancer. 102
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial 101
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 100
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 99
Aspergillosis superinfection as a cause of death of crizotinib-induced interstitial lung disease successfully treated with high-dose corticosteroid therapy 99
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 99
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 96
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 95
Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG) 93
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 93
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 92
An alternating regimen of irinotecan/ 5-fluorouracil/folinic acid and oxaliplatin/ 5-fluorouracil/folinic acid in metastatic colorectal cancer: a Phase II trial 92
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 91
Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma 89
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 89
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 88
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 88
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. 87
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 83
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 83
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 77
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 74
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? 66
Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma 65
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 63
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 63
Dynamic Susceptibility Contrast MR Imaging inGlioblastomas: Correlation of Whole-TumorHistogram Analysis of the Normalized CerebralBlood Volume and Vascular Permeability withHistopathologic and Molecular Markers of TumorAggressiveness 61
Targeted therapy with trastuzumab in dysplasia and adenocarcinoma arising in Barrett’s esophagus: a traslational approach 60
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies 60
Comparison of the prognostic classification with recursive partitioning analysis (RPA) and general prognostic assessment (GPA) in a retrospective analysis of 430 patients with brain metastases 58
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 57
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 56
TOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinoma 55
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 55
Targeted therapy with trastuzumab in Barrett’s dysplasia and adenocarcinoma: a translational approach 53
Topo IIα and HER-2/neu Overexpression/Amplification in Barrett's Esophagus, Dysplasia and Adenocarcinoma 53
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 53
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 51
null 51
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 50
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 50
Retrospective analysis of 107 patients whit localized extranodal limphoma of the head and neck treated with radiotherapy alone or combined modality treatment: final analysis of response rate, survival and pattern of relapse 49
HER-2 overexpression/amplification in esophageal dysplasia predicts early transition to adenocarcinoma: a clinico-pathologic study 49
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 46
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 46
HER-2/neu in Barrett’s esophagus: immunohistochemistry and fluorescence in situ hybridization (FISH) to identify a new subgroup of patients. 46
Could a comprehensive urinary endogenous steroidal profile improve the accuracy of prostate-specific antigen screening? 46
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 46
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs 45
Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases 43
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 43
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 42
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 41
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 41
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative study 41
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli 40
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 38
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases 37
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 36
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 36
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 34
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 34
Is BMI a reliable prognostic parameter in metastatic prostate cancer patients? 34
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 33
Totale 8.848
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.544
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.544
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020811 0 0 0 0 0 0 0 217 177 206 85 126
2020/20211.656 52 175 110 216 103 173 52 171 150 214 123 117
2021/2022848 67 82 30 96 22 53 36 56 43 108 64 191
2022/2023823 106 53 42 63 70 191 5 74 119 22 44 34
2023/20241.474 71 41 133 93 104 269 46 79 226 69 49 294
2024/20251.818 50 47 62 557 406 297 276 123 0 0 0 0
Totale 9.855